STOCK TITAN

Bio-Techne to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Bio-Techne (NASDAQ: TECH) has announced its participation in three major healthcare investor conferences in September 2025. The company will present at the Wells Fargo Healthcare Conference on September 3 at 10:15 AM EDT, the Baird Global Healthcare Conference on September 9 at 9:05 AM EDT, and the Morgan Stanley Global Healthcare Conference on September 10 at 10:45 AM EDT.

Investors can access live webcasts of all presentations through Bio-Techne's Investor Relations website under the IR Calendar page.

Bio-Techne (NASDAQ: TECH) sarà presente a tre importanti conferenze per investitori nel settore sanitario a settembre 2025. La società terrà una presentazione al Wells Fargo Healthcare Conference il 3 settembre alle 10:15 AM EDT, al Baird Global Healthcare Conference il 9 settembre alle 9:05 AM EDT e al Morgan Stanley Global Healthcare Conference il 10 settembre alle 10:45 AM EDT.

Gli investitori potranno seguire tutte le presentazioni in diretta via webcast attraverso il sito Investor Relations di Bio-Techne, nella pagina IR Calendar.

Bio-Techne (NASDAQ: TECH) ha anunciado su participación en tres importantes conferencias para inversores del sector sanitario en septiembre de 2025. La compañía presentará en el Wells Fargo Healthcare Conference el 3 de septiembre a las 10:15 AM EDT, en el Baird Global Healthcare Conference el 9 de septiembre a las 9:05 AM EDT y en el Morgan Stanley Global Healthcare Conference el 10 de septiembre a las 10:45 AM EDT.

Los inversores podrán acceder a las retransmisiones en directo de todas las presentaciones a través del sitio web de Relaciones con Inversores de Bio-Techne, en la página IR Calendar.

Bio-Techne (NASDAQ: TECH)는 2025년 9월에 열리는 주요 헬스케어 투자자 컨퍼런스 세 곳에 참여한다고 발표했습니다. 회사는 Wells Fargo Healthcare Conference에서 9월 3일 오전 10:15(EDT)에, Baird Global Healthcare Conference에서 9월 9일 오전 9:05(EDT)에, Morgan Stanley Global Healthcare Conference에서 9월 10일 오전 10:45(EDT)에 발표를 진행합니다.

투자자들은 Bio-Techne의 투자자 관계(Investor Relations) 웹사이트 내 IR Calendar 페이지를 통해 모든 발표의 생중계 웹캐스트를 시청할 수 있습니다.

Bio-Techne (NASDAQ: TECH) a annoncé sa participation à trois grandes conférences investisseurs healthcare en septembre 2025. La société présentera au Wells Fargo Healthcare Conference le 3 septembre à 10h15 EDT, au Baird Global Healthcare Conference le 9 septembre à 9h05 EDT et au Morgan Stanley Global Healthcare Conference le 10 septembre à 10h45 EDT.

Les investisseurs pourront accéder aux webcasts en direct de toutes les présentations via la rubrique Investor Relations du site de Bio-Techne, sur la page IR Calendar.

Bio-Techne (NASDAQ: TECH) hat seine Teilnahme an drei großen Healthcare-Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen wird am Wells Fargo Healthcare Conference am 3. September um 10:15 Uhr EDT, am Baird Global Healthcare Conference am 9. September um 9:05 Uhr EDT und am Morgan Stanley Global Healthcare Conference am 10. September um 10:45 Uhr EDT präsentieren.

Investoren können alle Präsentationen live per Webcast über die Investor-Relations-Website von Bio-Techne auf der IR Calendar-Seite verfolgen.

Positive
  • None.
Negative
  • None.

MINNEAPOLIS, Aug. 27, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

2025 Wells Fargo Healthcare Conference
September 3, 2025
10:15 AM EDT

Baird 2025 Global Healthcare Conference
September 9, 2025
9:05 AM EDT

Morgan Stanley 23rd Annual Global Healthcare Conference
September 10, 2025
10:45 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: LinkedIn, X or YouTube.

Contact:  David Clair, Vice President, Investor Relations & Corporate Development
               david.clair@bio-techne.com

BT Logo (PRNewsfoto/Bio-Techne Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302539292.html

SOURCE Bio-Techne Corporation

FAQ

When is Bio-Techne (TECH) presenting at the Wells Fargo Healthcare Conference 2025?

Bio-Techne will present at the Wells Fargo Healthcare Conference on September 3, 2025 at 10:15 AM EDT.

How can investors watch Bio-Techne's conference presentations in September 2025?

Investors can access live webcasts of all presentations through Bio-Techne's Investor Relations website at the IR Calendar page.

Which investor conferences will Bio-Techne (TECH) attend in September 2025?

Bio-Techne will present at three conferences: the Wells Fargo Healthcare Conference (Sept 3), Baird Global Healthcare Conference (Sept 9), and Morgan Stanley Global Healthcare Conference (Sept 10).

What time is Bio-Techne's presentation at the Morgan Stanley Healthcare Conference 2025?

Bio-Techne will present at the Morgan Stanley Global Healthcare Conference on September 10, 2025 at 10:45 AM EDT.
Bio-Techne Corp

NASDAQ:TECH

TECH Rankings

TECH Latest News

TECH Latest SEC Filings

TECH Stock Data

8.83B
153.84M
1.09%
102.49%
4.04%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
MINNEAPOLIS